Publication | Open Access
Evaluation of the Short‐, Mid‐, and Long‐Term Effects of Tofacitinib on Lymphocytes in Patients With Rheumatoid Arthritis
50
Citations
27
References
2018
Year
Our findings indicate that monitoring of ALC alone appears to be adequate to assess infection risk in tofacitinib-treated patients with RA.
| Year | Citations | |
|---|---|---|
Page 1
Page 1